Virtual Group Therapy for IBD Patients With Anxiety and Depression
Not applicable · Testing Group Psychotherapy Intervention · 1 site · University of Chicago
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Group Psychotherapy Intervention (a behavioral program) as a possible treatment. Condition(s) listed: Crohn's Disease (CD), Ulcerative Colitis (UC) and Inflammatory Bowel Diseases (IBD).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- 18+ years of age
- Patients with Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis)
- English-speaking
Plus 2 more requirement(s). There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 16 participants are expected to take part.
- Start date: 2026-09 (planned).
- Main results expected around 2027-06 (estimate from the record).
- 1 study site listed in United States.
Main thing being measured
- Determine acceptability of a 10-session, group-based, virtual treatment guided by the Mind over Mood treatment manual in patients with IBD with clinically significant depression and/or anxiety (End of intervention at week 10)
In the researchers’ words
This study is being done to better understand the complex relationship between mental health and Inflammatory Bowel Disease (IBD), with a particular focus on symptoms of depression and anxiety. While depression and anxiety have traditionally been viewed as reactions to the burden of living with IBD, new research suggests that the biological factors involved in IBD may also contribute directly to these mental health…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Crohn's Disease (CD); Ulcerative Colitis (UC); Inflammatory Bowel Diseases (IBD); Anxiety; Depression |
| Lead sponsor | University of Chicago |
| Collaborators | GI Research Foundation |
| Enrollment | 16 (estimated) |
| Start date | 2026-09 |
| Primary completion (est.) | 2027-06 |
| First posted | 2026-09-01 |
| Last updated | 2026-09-01 |
| Official title | Group-based Virtual Psychotherapy Intervention for Anxiety and Depression in Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT07796568 |
Interventions
- Group Psychotherapy Intervention (Behavioral)
Participants will engage in a course of ten, 120-minute sessions of group psychotherapy. The intervention will be guided by the Mind Over Mood treatment manual. Mind Over Mood is a manual that is published and commonly used to treat depression and anxiety as guided by a therapist and for self-help. For this study, the manual will be adapted for patients with IBD. Session content will include inter…
Full eligibility criteria (from the record)
Inclusion Criteria: * 18+ years of age * Patients with Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) * English-speaking * Patients with score ≥10 on General Anxiety Disorder-7 (GAD-7) questionnaire (considered moderate or higher anxiety symptoms) or ≥10 on the Patient Health Questionnaire-9 (PHQ-9) (considered moderate or higher depressive symptoms) within 3 months * Able to provide written consent Exclusion Criteria: * Unwilling and/or unable to participate * Non-English speakers * Unable to understand the instructions or to consent to participation in the study, including patients with a diagnosed cognitive impairment
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago | Chicago, Illinois | United States |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.